Co-Diagnostics, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1897631057
USD
0.39
0.04 (10.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Co-Diagnostics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-37.00
-38.00
-18.00
45.00
42.00
-6.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
2.00
5.00
6.00
-2.00
-16.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-29.00
-22.00
6.00
41.00
28.00
-5.00
Cash Flow from Investing Activities
17.00
15.00
-58.00
4.00
-5.00
0.00
Cash Flow from Financing Activities
0.00
-1.00
-14.00
0.00
19.00
5.00
Net Cash Inflow / Outflow
-11.00
-8.00
-65.00
45.00
42.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Co-Diagnostics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-37.58164
-30.437
-7.00
-23.47%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2.754651
-1.412
3.00
295.09%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-29.155045
-24.149
-5.00
-20.73%
Cash Flow from Investing Activities
17.070797
-0.187
17.00
9228.77%
Cash Flow from Financing Activities
0.103914
14.184
-14.00
-99.27%
Net Cash Inflow / Outflow
-11.980334
-10.152
-1.00
-18.01%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -32.03% vs -436.17% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-29.16
-22.08
-32.03%